Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-22-080510
Filing Date
2022-03-21
Accepted
2022-03-21 16:02:18
Documents
8
Effectiveness Date
2022-03-21

Document Format Files

Seq Description Document Type Size
1 POSASR d335806dposasr.htm POSASR 297630
2 EX-5.1 d335806dex51.htm EX-5.1 24846
3 EX-23.2 d335806dex232.htm EX-23.2 1124
4 EX-FILING FEES d335806dexfilingfees.htm EX-FILING FEES 57411
5 GRAPHIC g335806g00m01.jpg GRAPHIC 34389
6 GRAPHIC g335806g0319042825550.jpg GRAPHIC 3252
7 GRAPHIC g335806g0319042826289.jpg GRAPHIC 1414
8 GRAPHIC g335806g17x00.jpg GRAPHIC 43888
  Complete submission text file 0001193125-22-080510.txt   489316
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-255833 | Film No.: 22755739
SIC: 2834 Pharmaceutical Preparations